Insulin-degrading enzyme higher in subjects with metabolic syndrome.
Sofer Y, Nash Y, Osher E, Fursht O, Goldsmith G, Nahary L, Shaklai S, Tordjman KM, Serebro M, Touati EB, Yacobi Bach M, Marcus Y, Tal B, Sack J, Shefer G, Margaliot M, Landis N, Goldiner I, Abu Ahmad W, Stern N, Benhar I, Frenkel D.
Sofer Y, et al. Among authors: touati eb.
Endocrine. 2021 Feb;71(2):357-364. doi: 10.1007/s12020-020-02548-2. Epub 2021 Jan 4.
Endocrine. 2021.
PMID: 33398768